from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0831c/-

LFCtreatmentdescriptionclass of inhibitor

0.267

Amikacinug/mL Amikacintranslation

0.131

Cap5-10ug/mL Capreomycintranslation

-1.611

Rox10-50 ug/mL Roxithromycintranslation

0.172

SM2-5 ug/mL Streptomycintranslation

-1.513

Tet5-10 ug/mL Tetracyclinetranslation

-0.189

Rif0.2-5ug/mL Rifampicintranscription

0.706

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.770

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.016

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.081

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.332

Clofazimine10-13 ug/mL Clofaziminerespiration

0.510

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.460

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.873

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.324

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.736

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.337

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.113

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.427

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.860

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.986

KCN5-20 ug/mL Potassium cyaniderespiration

0.540

NaN30.2-2 mM Sodium aziderespiration

0.568

Nigericin50 uM Nigericinrespiration

-0.611

TRC10-150 ug/mL Triclosanrespiration

-1.032

TRZ10-25 ug/mL Thioridazinerespiration

-2.618

Valinomycin0.5-10 uM Valinomycinrespiration

0.985

ZnSO42 mM ZnSO4respiration

0.367

menadione6-10 ug/mL Menadionerespiration

0.253

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.635

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.288

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.110

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.212

NRP_1Non-replicating persistence stage 1dosRassociated

0.101

Amp0.2mg/mL AmpicillincellWall

0.340

Cephalexin20-100 ug/mL CephalexincellWall

0.975

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.529

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.106

EMB10-20 ug/mL EthambutolcellWall

0.433

Eta12-40 ug/mL EthionamidecellWall

-0.148

INH0.2-0.4 ug/mL IsoniazidcellWall

0.489

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.457

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.924

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.063

BZA0.12 mg/mL BenzamidearomaticAmides

0.060

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.120

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.229

H2O24 mM hydrogen peroxideDNAdamaging

1.244

Levo10 ug/mL LevofloxacinDNAdamaging

0.271

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.901

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.420

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.036

UVUV-irradiationDNAdamaging

-1.098

ARP41-4 ug/mL Antitubercular compound ARP4?

0.684

Antimycin12.5-50 ug/mL Antimycin A?

0.987

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.078

PA_110-50 ug/mL Antitubercular compound PA-1?

1.237

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.718

PA8240.2-2 ug/mL PA-824?

-0.268

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.093

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.005

Verapamil50 uM Verapamil?

0.972

mercaptoethanol2 mM 2-Mercaptoethanol?

0.948

methoxatin10-20 ug/mL Methoxatin?